Tianda Pharmaceuticals Ltd. (HK:0455) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Tianda Pharmaceuticals has entered into a new framework agreement with TCH (China) Group, revising the expiry date of their existing agreement to align with their financial year-end and extending their collaboration until 2027. This renewal involves the continued purchase of packaging products and design services, highlighting a strategic move to streamline operations and enhance market agility. With these transactions, Tianda aims to solidify its market position while complying with regulatory requirements.
For further insights into HK:0455 stock, check out TipRanks’ Stock Analysis page.